You are here

  • Home
  • Archive
  • Volume 18, Issue 4
  • HIV consensus guideline recommends antiretroviral treatment regardless of CD4 count, new regimens and possible regimen change for chronic low level viraemia

Article Text

Article menu
Download PDFPDF
Therapeutics
Systematic review
HIV consensus guideline recommends antiretroviral treatment regardless of CD4 count, new regimens and possible regimen change for chronic low level viraemia
  1. R Chris Rathbun
  1. Department of Pharmacy: Clinical/Administrative Sciences, OUHSC College of Pharmacy, Clinical/Administrative Sciences , Oklahoma City, Oklahoma, USA
  1. Correspondence to : R Chris Rathbun
    Department of Pharmacy: Clinical/Administrative Sciences, OUHSC College of Pharmacy, Clinical/Administrative Sciences, 1110 N. Stonewall, Rm 206, Oklahoma City, OK 73117, USA; Chris-Rathbun{at}ouhsc.edu

https://doi.org/10.1136/eb-2012-101010

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 2012;308(4):387–402.OpenUrlCrossRefPubMedWeb of Science

    Context

    Recommendations for indications and timing of antiretroviral therapy have continued to evolve since the introduction of highly active antiretroviral therapy. Updated guidelines from the International Antiviral Society (IAS)—USA Panel have recently been issued to inform clinicians in resource-rich settings of best practices based on treatment advances and increased understanding of HIV pathophysiology.

    Methods

    Consensus antiretroviral therapy guidelines were last issued from the IAS-USA Panel in July 2010. The current update is based on a systematic search of literature indexed in PubMED and EMBASE between July 2010 and May 2012, scientific conference abstracts, data/safety monitoring board and regulatory agency reports …

    View Full Text

    Footnotes

    • Competing interests None.